Medical Device News Magazine

Christine Senn, PhD Appointed Senior Vice President, Head of Site-Sponsor Innovation at Advarra

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Christine Senn, PhD

Advarra, the market leader in regulatory review solutions and clinical research technology for sites and sponsors, welcomes clinical industry veteran Christine Senn, PhD, as Senior Vice President, Head of Site-Sponsor Innovation. With extensive site leadership experience and a longstanding personal goal to drive site-sponsor collaboration, Senn will lead Advarra’s effort to remove barriers between stakeholders and connect a siloed clinical research ecosystem – ultimately, to accelerate clinical trials.

Responsibilities

At Advarra, Chistine Senn will serve as Chair of the Site-Sponsor Consortium – a collaborative body now in its second year – and as Chair of Advarra’s Customer Advisory Board. She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra’s mission. Further, Senn is excited to expand and elevate Advarra’s tightknit site community that collaborates in an exclusive online portal to transform clinical research and culminates each year at the Onsemble Conference.

Senn Comments

“Fostering collaboration of all clinical research stakeholders has been important to me throughout my career,” said Christine Senn. “For decades, there has been a huge disparity between the good intention of sponsor leadership and the reality in practice at the site level. Advarra gets this – just look at its Longboat solution as evidence of the company’s commitment to connecting a currently disconnected ecosystem. I am inspired to lead Advarra’s mission and execute transformative ideas about how to accomplish it.”

Clinical Trial Career

Senn began her clinical trial career at the University of Vermont College of Medicine while pursuing her doctorate in clinical psychology. She then spent 16+ years in various leadership positions including Chief Operating Officer at IACT Health, which later became Centricity Research, a top site network with more than 40 clinical research sites in the U.S. and Canada. Senn was also the 2023 Chair of the Association of Clinical Research Professionals (ACRP), is an ACRP Fellow (FACRP), and is double certified as a Certified Clinical Research Coordinator (CCRC) and Certified Principal Investigator (CPI).

“Christine is an industry superstar with extensive clinical trial experience, particularly from the critical, patient-facing site perspective,” said Advarra CEO Gadi Saarony. “We are driving full throttle on our mission to connect the ecosystem of sites and sponsors, and Christine brings the expertise and tenacity to propel us forward in that effort with the ultimate goal of speeding trials.”

Christine Senn will be presenting at Advarra’s 35th annual Onsemble Conference March 18-21 in Phoenix, AZ. Onsemble is the industry’s largest gathering of clinical research site professionals, including cancer centers, children’s hospitals, research consortia, academic medical centers, healthcare systems, and more.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”